MEDIWOUND LTD.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $8.4M | $16.8M | $9.3M | $5.9M | $2.7M |
| Product Sales | $2.5M | $1.2M | $616.0K | $516.0K | $59.0K |
| Collaboration and Development | $5.9M | $15.7M | $8.7M | $5.4M | $2.6M |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-13.7M | $-20.2M | $-21.2M | — | — |
| Operating Margin | -162.1% | -119.8% | -227.7% | — | — |
| Interest Expense | — | — | — | — | — |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-22.1M | $-18.9M | $-22.1M | — | — |
| Net Margin | -262.3% | -112.2% | -237.0% | — | — |
| EPS (Basic) | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — |
| Shares Outstanding (Basic) | 27.0M | — | — | — | — |
| Shares Outstanding (Diluted) | 27.0M | — | — | — | — |
| Dividends Per Share | — | — | — | — | — |